Top story · Business · 23 Oct 2026
Proteomics secures US patent for PromarkerEndo, plans national blood-test rollout with 2027 launch
Perth-based Proteomics has been granted a US patent for its PromarkerEndo blood test and is preparing a national rollout, while a company restructure has led to job cuts. The biotech is targeting a commercial launch in 2027 as it transitions from development to scaling operations.
Read the full story




